A collaboration involving physicians and patients has identified 22 research priorities for bronchiectasis research. According to the European Multicentre Bronchiectasis Audit and Research Collaboration (EMBARC) current knowledge was limited by the fact that treatment was mainly extrapolated from cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD), or based on expert opinions. “High-quality evidence is still missing…large ...
Already a member?
Enter your email to keep reading.